Market Overview:
The global biodegradable and bioabsorbable stents market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD), rising geriatric population, and technological advancements in stent technology. However, the high cost of biodegradable and bioabsorbable stents may restrain the growth of this market during the forecast period. Based on type, the global biodegradable and bioabsorbable stents market is segmented into polymer-based stents and metal-based stents. The polymer-based segment is expected to dominate the global biodegradable and bioabsorbable stents market during the forecast period owing to its advantages such as low profile, conformability, radiopacity, ease of deployment, etc., over metal-based stents.
Product Definition:
A biodegradable stent is a medical device made from materials that can break down over time inside the body. A bioabsorbable stent is a medical device made from materials that will dissolve over time inside the body. The purpose of a biodegradable or bioabsorbable stent is to keep an artery open after angioplasty, a procedure in which a balloon-like catheter is inserted into the artery to widen it. Once the obstruction has been cleared, the stent remains in place to keep the artery open and prevent it from narrowing again.
Polymer Based:
Polymer-based stents are made from synthetic polymers and natural polymers. The most commonly used synthetic polymer is Polyethylene (PE), which is derived from crude oil. Stents made from other synthetic polymers include Polypropylene (PP), Polystyrene (PS), and Polyamide 6/6 (PA6). Natural polymer includes rubber, cellulose, collagen, starch & derivatives of starch such as hydrogels & gels.
Metal Based:
Metal-based stents are used in the biodegradable and bioabsorbable stents market. Metal-based stents are made of various metals such as stainless steel, titanium, nickel chromium, copper & aluminum. These metal based products have a wide range of applications in medical field including interventional cardiology and interventional radiology among others.
Application Insights:
The coronary artery disease segment dominated the global market in terms of revenue share in 2017. This is due to the increasing prevalence of coronary artery diseases, which are one of the leading causes of death globally. According to a study published by NCBI, it is estimated that around 370,000 deaths occur due to such diseases every year in U.S., and over 1 million worldwide.
Global biodegradable.
Moreover, according to another study published by NCBI it is estimated that around 37% out-of-hospital cardiac arrest cases have a history of heart attack or stroke within 6 months before suffering from cardiac arrest. Henceforth, such factors are expected to increase demand for BVSs during the forecast period thus driving growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing cases of coronary artery disease, technological advancements, and high adoption of biologics and stents. Europe is expected to witness significant growth over the forecast period owing to rising geriatric population prone to various cardiovascular diseases (CVDs). Moreover, growing awareness about new technologies such as biodegradable & bioabsorbable stents is anticipated to drive this regional market. Asia Pacific region is projectedto exhibit lucrative growth during the forecast period due its large population base suffering from CVDs and growing medical tourism industry in emerging economies such as India & China.
Major players operating in this space include Medtronic; Boston Scientific Corporation; Integra LifeSciences Inc.; Stryker; Zimmer Biomet Holdings Inc.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Rising geriatric population
- Growing demand for minimally invasive surgeries
- Technological advancements in stent manufacturing process
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Biodegradable and Bioabsorbable Stents Market Research Report
By Type
Polymer Based, Metal Based
By Application
Coronary Artery Disease, Peripheral Artery Disease
By Companies
Abbott Laboratories, Kyoto Medical Planning, Reva Medical, Elixir Medical Corporation, Amaranth Medical, Terumo Corporation, Arterius Limited, Biotronik, Meril Life Sciences, Xenogenics Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Biodegradable and Bioabsorbable Stents Market Report Segments:
The global Biodegradable and Bioabsorbable Stents market is segmented on the basis of:
Types
Polymer Based, Metal Based
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coronary Artery Disease, Peripheral Artery Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Kyoto Medical Planning
- Reva Medical
- Elixir Medical Corporation
- Amaranth Medical
- Terumo Corporation
- Arterius Limited
- Biotronik
- Meril Life Sciences
- Xenogenics Corporation
Highlights of The Biodegradable and Bioabsorbable Stents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymer Based
- Metal Based
- By Application:
- Coronary Artery Disease
- Peripheral Artery Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biodegradable and Bioabsorbable Stents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioabsorbable and biodegradable stents are medical devices that are designed to dissolve or break down in the body over time. This means that they can be removed without any additional surgery or treatment.
Some of the key players operating in the biodegradable and bioabsorbable stents market are Abbott Laboratories, Kyoto Medical Planning, Reva Medical, Elixir Medical Corporation, Amaranth Medical, Terumo Corporation, Arterius Limited, Biotronik, Meril Life Sciences, Xenogenics Corporation.
The biodegradable and bioabsorbable stents market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biodegradable and Bioabsorbable Stents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biodegradable and Bioabsorbable Stents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biodegradable and Bioabsorbable Stents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biodegradable and Bioabsorbable Stents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biodegradable and Bioabsorbable Stents Market Size & Forecast, 2018-2028
4.5.1 Biodegradable and Bioabsorbable Stents Market Size and Y-o-Y Growth
4.5.2 Biodegradable and Bioabsorbable Stents Market Absolute $ Opportunity
Chapter 5 Global Biodegradable and Bioabsorbable Stents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biodegradable and Bioabsorbable Stents Market Size Forecast by Type
5.2.1 Polymer Based
5.2.2 Metal Based
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biodegradable and Bioabsorbable Stents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biodegradable and Bioabsorbable Stents Market Size Forecast by Applications
6.2.1 Coronary Artery Disease
6.2.2 Peripheral Artery Disease
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biodegradable and Bioabsorbable Stents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biodegradable and Bioabsorbable Stents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biodegradable and Bioabsorbable Stents Analysis and Forecast
9.1 Introduction
9.2 North America Biodegradable and Bioabsorbable Stents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biodegradable and Bioabsorbable Stents Market Size Forecast by Type
9.6.1 Polymer Based
9.6.2 Metal Based
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biodegradable and Bioabsorbable Stents Market Size Forecast by Applications
9.10.1 Coronary Artery Disease
9.10.2 Peripheral Artery Disease
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biodegradable and Bioabsorbable Stents Analysis and Forecast
10.1 Introduction
10.2 Europe Biodegradable and Bioabsorbable Stents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biodegradable and Bioabsorbable Stents Market Size Forecast by Type
10.6.1 Polymer Based
10.6.2 Metal Based
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biodegradable and Bioabsorbable Stents Market Size Forecast by Applications
10.10.1 Coronary Artery Disease
10.10.2 Peripheral Artery Disease
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biodegradable and Bioabsorbable Stents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biodegradable and Bioabsorbable Stents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biodegradable and Bioabsorbable Stents Market Size Forecast by Type
11.6.1 Polymer Based
11.6.2 Metal Based
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biodegradable and Bioabsorbable Stents Market Size Forecast by Applications
11.10.1 Coronary Artery Disease
11.10.2 Peripheral Artery Disease
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biodegradable and Bioabsorbable Stents Analysis and Forecast
12.1 Introduction
12.2 Latin America Biodegradable and Bioabsorbable Stents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biodegradable and Bioabsorbable Stents Market Size Forecast by Type
12.6.1 Polymer Based
12.6.2 Metal Based
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biodegradable and Bioabsorbable Stents Market Size Forecast by Applications
12.10.1 Coronary Artery Disease
12.10.2 Peripheral Artery Disease
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biodegradable and Bioabsorbable Stents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biodegradable and Bioabsorbable Stents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biodegradable and Bioabsorbable Stents Market Size Forecast by Type
13.6.1 Polymer Based
13.6.2 Metal Based
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biodegradable and Bioabsorbable Stents Market Size Forecast by Applications
13.10.1 Coronary Artery Disease
13.10.2 Peripheral Artery Disease
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biodegradable and Bioabsorbable Stents Market: Competitive Dashboard
14.2 Global Biodegradable and Bioabsorbable Stents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Kyoto Medical Planning
14.3.3 Reva Medical
14.3.4 Elixir Medical Corporation
14.3.5 Amaranth Medical
14.3.6 Terumo Corporation
14.3.7 Arterius Limited
14.3.8 Biotronik
14.3.9 Meril Life Sciences
14.3.10 Xenogenics Corporation
